home.social

#cardiovascular-diseases — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #cardiovascular-diseases, aggregated by home.social.

fetched live
  1. Researchers from our university studied the effects of #weightloss injections in patients who have #heartfailure with preserved ejection fraction. The study provides strong evidence that these injections can reduce health risks: go.tum.de/964152

    #CardiovascularDiseases
    📷 C. Rudah / iStock

  2. 💔 #CardiovascularDiseases, aka CVD, affect 55 million people in Europe alone, and cases are on the rise.
    👩‍🔬 IHI project iCARE4CVD is working towards a more personalised approach to CVD care, from identifying those at risk right through to caring for people with advanced disease.
    👉 Find out more in today's #IHISummerOfScience europa.eu/!nP7Gqm
    #IHITransformingHealth #HorizonEU #HeartDisease #health #research

  3. #WorldMusicDay 🎼
    Marie Herzfeld-Schild @mdwwien & Elaine Chew @KingsCollegeLon join forces to show music's influences on human emotions through the ages & how it works via modern tech.
    👉 bit.ly/43W8Ina
    #neurobiology #cardiovasculardiseases @HorizonMagEu t.co/C1XT4zrzX1

    🐦🔗: n.respublicae.eu/ERC_Research/

  4. 💊 Customising prescriptions to match each patient's individual biological traits has the potential to bring about significant advancements in #health.

    More about @ProfNiemi's work @helsinkiuni 👉 bit.ly/3VNlKRr

    #cardiovasculardiseases #pharmacology @HorizonMagEU

    🐦🔗: n.respublicae.eu/ERC_Research/

  5. Wie een #zoetje in de koffie of thee mikt in plaats van #suiker en denkt dat het gezonder is, kan daar maar beter mee stoppen. Want dat is het niet.

    Nieuw gepubliceerd onderzoek in #BritishMedicalJournal wijst duidelijk in de richting van verhoogd risico op hart-vaatziekten, met name als er aspartaam, sucralose en acesulfaam-K in zit.

    #kunstmatigezoetstof #sweeteners #cardiovasculardiseases #koffie #thee #coffee #tea #VoedingsToot #Research

    bmj.com/content/378/bmj-2022-0